Literature DB >> 12607105

Human cytomegalovirus glycoprotein B genotypes in immunocompetent, immunocompromised, and congenitally infected Italian populations.

S Arista1, S De Grazia, G M Giammanco, P Di Carlo, E Iannitto.   

Abstract

Human cytomegalovirus (HCMV) strains, obtained from immunocompetent and immunocompromised Italian hosts, were typed with glycoprotein B (gB) gene restriction analysis. A predominant circulation of HCMV strains with gB type 2 and 3 was detected in both the immunocompetent host with a primary HCMV infection and the immunocompromised host with or without HCMV disease. No association between gB types and subjects with different risks of developing HCMV disease was found. All four gB genotypes were capable of causing congenital infection in Italian babies, with gB type 1 accounting for 50% of the strains examined in symptomatic infants and a remarkable incidence of gB type 4 viruses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12607105     DOI: 10.1007/s00705-002-0941-0

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  9 in total

1.  Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections.

Authors:  E Paradowska; M Studzińska; D Nowakowska; J Wilczyński; M Rycel; P Suski; Z Gaj; B Kaczmarek; Z Zbróg; Z J Leśnikowski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-04       Impact factor: 3.267

2.  Human cytomegalovirus UL144 gene polymorphisms in congenital infections.

Authors:  Olivier Picone; Jean-Marc Costa; Marie-Laure Chaix; Yves Ville; Christine Rouzioux; Marianne Leruez-Ville
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

3.  Molecular Detection and Glycoprotein B (UL55) Genotyping of Cytomegalovirus among Sudanese Renal Transplant Recipients.

Authors:  Hind Haidar Ahmed; Hisham N Altyab; Samar M Saeed; Wafaa Mohammed Abdalla; Alfadil Elobeid Omer
Journal:  Biomed Res Int       Date:  2022-05-31       Impact factor: 3.246

4.  Mixed infections with distinct cytomegalovirus glycoprotein B genotypes in Polish pregnant women, fetuses, and newborns.

Authors:  M Rycel; W Wujcicka; B Zawilińska; E Paradowska; P Suski; Z Gaj; J Wilczyński; Z Leśnikowski; D Nowakowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-28       Impact factor: 3.267

5.  Genotyping of Cytomegalovirus from Symptomatic Infected Neonates in Iraq.

Authors:  Sevan N Alwan; Haidar A Shamran; Avan H Ghaib; Haider S Kadhim; Qasim S Al-Mayah; Atheer J Al-Saffar; Ali H Bayati; Hala S Arif; Jianmin Fu; Brian L Wickes
Journal:  Am J Trop Med Hyg       Date:  2019-04       Impact factor: 2.345

6.  Genotypes of glycoprotein B gene among the Indian symptomatic neonates with congenital CMV infection.

Authors:  Agniswar Sarkar; Dipanwita Das; Sabbir Ansari; Rajendra Prasad Chatterjee; Lopamudra Mishra; Biswanath Basu; Sanat Kumar Ghosh; Mala Bhattacharyay; Nilanjan Chakraborty
Journal:  BMC Pediatr       Date:  2019-08-22       Impact factor: 2.125

7.  Development of highly efficient protocols for extraction and amplification of cytomegalovirus DNA from dried blood spots for detection and genotyping of polymorphic immunomodulatory genes.

Authors:  Christian Berg; Martin B Friis; Mette M Rosenkilde; Thomas Benfield; Lene Nielsen; Hans R Lüttichau; Thomas Sundelin
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

Review 8.  Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity.

Authors:  Hsuan-Yuan Wang; Sarah M Valencia; Susanne P Pfeifer; Jeffrey D Jensen; Timothy F Kowalik; Sallie R Permar
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.818

9.  Association of CMV genomic mutations with symptomatic infection and hearing loss in congenital CMV infection.

Authors:  G Clement Dobbins; Amit Patki; Dongquan Chen; Hemant K Tiwari; Curtis Hendrickson; William J Britt; Karen Fowler; Jake Y Chen; Suresh B Boppana; Shannon A Ross
Journal:  BMC Infect Dis       Date:  2019-12-10       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.